Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review

被引：0
|
作者：
Duseja, Ajay Kumar [1 ]
De, Arka [1 ]
Mehta, Manu [1 ]
Singh, Priya [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1430
引用
收藏
页码：S1090 / S1090
页数：1
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [22] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):
  • [23] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
  • [24] Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review
    Ladaru, Anca
    Balanescu, Paul
    Stan, Mihaela
    Codreanu, Ioana
    Anca, Ioana Alina
    BIOMARKERS, 2016, 21 (02) : 102 - 114
  • [25] Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Kim, Jeong Woo
    Lee, Chang Hee
    Kim, Baek-Hui
    Lee, Young-Sun
    Hwang, Soon-Young
    Park, Bit Na
    Park, Yang Shin
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (03) : 1815 - 1829
  • [26] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [27] PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE, HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS, AND LIVER FIBROSIS IN PATIENTS WITH OSTEOARTHRITIS
    Kalligeros, Markos
    Vassilopoulos, Athanasios
    Vassilopoulos, Stephanos
    Wands, Jack R.
    Promrat, Kittichai
    HEPATOLOGY, 2023, 78 : S1034 - S1035
  • [28] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134
  • [29] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [30] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
12345